Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Feagan

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Alimentary Pharmacology & Therapeutics|May 25, 2016
Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitisW J Sandborn, B R Bhandari, R Fogel, et al.
Alimentary Pharmacology & Therapeutics|June 20, 2018
An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's diseaseF Rieder, D Bettenworth, C Ma, et al.
Alimentary Pharmacology & Therapeutics|July 16, 2013
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel diseaseR Khanna, B D Sattin, W Afif, et al.
Alimentary Pharmacology & Therapeutics|February 21, 2018
Reliability of histologic assessment in patients with eosinophilic oesophagitisM J Warners, C A Ambarus, A J Bredenoord, et al.
Alimentary Pharmacology & Therapeutics|February 7, 2017
Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn's diseaseV Jairath, G Zou, C E Parker, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Alimentary Pharmacology & Therapeutics|May 25, 2016
Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitisW J Sandborn, B R Bhandari, R Fogel, et al.
Alimentary Pharmacology & Therapeutics|June 20, 2018
An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's diseaseF Rieder, D Bettenworth, C Ma, et al.
Alimentary Pharmacology & Therapeutics|July 16, 2013
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel diseaseR Khanna, B D Sattin, W Afif, et al.
Alimentary Pharmacology & Therapeutics|February 21, 2018
Reliability of histologic assessment in patients with eosinophilic oesophagitisM J Warners, C A Ambarus, A J Bredenoord, et al.
Alimentary Pharmacology & Therapeutics|February 7, 2017
Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn's diseaseV Jairath, G Zou, C E Parker, et al.
Pageof 8